Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=6
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=6
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=6
PubPharm (62.745)
51
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL : Phase I Study of the Administration of T Lymphocytes Co-Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
52
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma : Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
53
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma : A Phase I Study of Autologous Activated T-cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch in Subjects With Relapsed/Refractory B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
54
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma : A Phase I Study of Autologous Activated T-Cells Expressing a 2nd Generation GD2 Chimeric Antigen Receptor, IL-15, and iCaspase9 Safety Switch Administered To Patients With Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
55
BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers : A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Topical BB-101 (rhNEGF) for the Treatment of Diabetic Lower Leg and Foot Ulcers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
56
Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST) : Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
57
Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis : Evaluation of a Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
58
A Study of SHP655 (rADAMTS13) in Sickle Cell Disease : A Phase 1 Randomized, Double-blind, Placebo-controlled, Multicenter, Ascending Dose, Safety and PK/PD Study of SHP655 (rADAMTS13) in Sickle Cell Disease at Baseline Health
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
59
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma : A Phase I Clinical Trial of Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
60
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. : Phase 1 Study of the Administration of T Lymphocytes Expressing the Kappa Chimeric Antigen Receptor (CAR) and CD28 Endodomain for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[6275]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
62.745
Aufsätze
62.745
E-Artikel
62.745
E-Ressourcen
Zeitschriftentitel
41.487
ClinicalTrials.gov
21.258
WHO International Clinical Trials Registry Plat...
Thema
62.745
610
Phase: Phase 1
62.735
Study Type: Interventional
31.764
Recruitment Status: Completed
9.379
Recruitment Status: Not yet recruiting
7.900
Recruitment Status: Recruiting
4.136
Medical Condition: Healthy
3.278
Recruitment Status: Authorised-recruitment may ...
3.206
Neoplasms
3.050
Recruitment Status: Terminated
2.334
Recruitment Status: Active, not recruiting
1.350
Lymphoma
1.331
Leukemia
1.318
Recruitment Status: Withdrawn
1.307
Recruitment Status: Unknown status
1.170
Carcinoma
1.086
Recruitment Status: Complete: follow-up complete
1.013
Medical Condition: Healthy Volunteers
916
Breast Neoplasms
817
Carcinoma, Non-Small-Cell Lung
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
35.450
2020-
25.769
2010-2019
1.526
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
62.465
Englisch
218
Unbestimmt
20
Spanisch
12
Französisch
6
Niederländisch
6
Italienisch
4
Deutsch
2
Dänisch
2
Finnisch
2
Norwegisch
2
Nyanja
2
Sanskrit
2
Schwedisch
2
Xhosa
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...